Results 51 to 60 of about 276,079 (291)

Microalbuminuria predicts contrast-induced nephropathy in patients with acute coronary syndrome

open access: yesREC: Interventional Cardiology (English Ed.), 2021
Introduction and objectives: Between 10% and 25% of patients hospitalized due to an acute coronary syndrome develop acute kidney injury, a condition associated with higher morbidity and mortality rates.
Yevgeniy Korolov   +6 more
doaj   +1 more source

Acute coronary syndromes and coronary intervention [PDF]

open access: yesEuropean Heart Journal, 2015
The current issue of the European Heart Journal is devoted to acute coronary syndromes (ACS) and coronary intervention. The editors were fortunate as prominent cardiologists from the Benelux countries (in close collaboration with the editors of our journal) agreed to summarize for 2014 the most important advances in these important subspecialties of ...
openaire   +2 more sources

CD147/Basigin: From Integrative Molecular Hub to Translational Therapeutic Target

open access: yesAdvanced Science, EarlyView.
This review conceptualizes CD147 as a fundamental “Energy‐Structure Coupler,” physically bridging metabolic flux (via MCTs) with morphogenetic plasticity (via integrins/MMPs) to drive cancer, infection, and autoimmunity. Addressing the “specificity paradox” that limits current translation, the authors chart a strategic roadmap—spanning logic‐gated ...
Xiang‐Min Yang   +2 more
wiley   +1 more source

Association between the C-reactive protein–albumin–lymphocyte index and severity of acute coronary syndrome: A retrospective study

open access: yesJournal of International Medical Research
Background The C-reactive protein–albumin–lymphocyte index integrates inflammatory and nutritional markers. However, its role in acute coronary syndrome remains unclear.
Tingting Wu   +4 more
doaj   +1 more source

КЛИНИЧЕСКИЙ ОПЫТ РЕАЛИЗАЦИИ ИНВАЗИВНОЙ СТРАТЕГИИ ЛЕЧЕНИЯ ОСТРОГО КОРОНАРНОГО СИНДРОМА БЕЗ СТОЙКОГО ПОДЪЕМА СЕГМЕНТА ST НА ЭКГ

open access: yesАрхивъ внутренней медицины, 2015
In article authors discuss invasive strategy of treatment of patients with acute coronary syndrome without ST elevation. 221 cases from CCU of hospital № 7 were analysed.
Ю. А. Прилуцкая   +1 more
doaj   +1 more source

Acute Coronary Syndromes [PDF]

open access: yesCirculation Research, 2014
An acute coronary syndrome (ACS) is the most ominous manifestation of coronary artery disease (CAD). The burden of ACS and its impact are striking. Cardiovascular disease is now the most common cause of mortality worldwide, and among cardiovascular deaths, the majority are attributable to CAD.1 As a result, although CAD in general is a major global ...
Valentin Fuster, Jason C. Kovacic
openaire   +1 more source

Chaperone‐Mediated Autophagic Degradation of USP9X in Macrophages Exacerbates Postmyocardial Infarction Inflammation and Cardiac Dysfunction

open access: yesAdvanced Science, EarlyView.
This study demonstrates that inflammatory stimuli induce the acetylation‐triggered, chaperone‐mediated autophagic degradation of ubiquitin‐specific peptidase 9 X‐linked (USP9X) in macrophages. USP9X acts as a macrophage “inflammation switch” after myocardial infarction (MI). USP9X loss destabilizes tumor necrosis factor receptor‐associated factor (TRAF)
Biqing Wang   +7 more
wiley   +1 more source

Gender diversity in the course of acute coronary syndrome

open access: yesActa Biomedica Scientifica, 2015
The article presents the results of the analysis of gender differences in patients hospitalized with diagnosis "acute coronary syndrome". The most common risk factor of acute coronary syndrome among men was smoking.
O. S. Donirova, B. A. Donirov
doaj  

Statins in Acute Coronary Syndromes

open access: yesCurrent Pharmaceutical Design, 2018
Background: Patients with acute coronary syndrome (ACS) frequently experience recurrent adverse events from the cardiovascular system comparing to either healthy individuals or individuals with stable coronary artery disease. This is attributed to the inflammatory cascade that is activated during ACS resulting in increased risk for rupture of ...
Vavuranakis, M.   +4 more
openaire   +3 more sources

CD3ɛ Nanobody‐Engineered Extracellular Vesicles Driving In Vivo Generation of BiTE‐Secreting CAR‐Ts for Solid Tumor Therapy With Memory Response and Minimal Immunogenicity

open access: yesAdvanced Science, EarlyView.
HEK‐293T‐derived CD3ε Nb‐engineered EVs to generate dual‐targeting CAR‐T cells directly in vivo. These EVs selectively deliver CAR.BiTE transgenes into T cells and reprogramed to HLA‐G/PD‐L1‐targeting effector cells with enhanced memory and persistence.
Shi‐Wei Huang   +27 more
wiley   +1 more source

Home - About - Disclaimer - Privacy